Meet us in Chicago, IL, during the 4th Annual Immuno-Oncology: BD&L and Investment Forum on June 1 2018!
Richard Godfrey will give a keynote presentation at 10:20 am (Central) entitled: “Selective AXL Inhibition as a Potential Cornerstone of Combination Cancer Therapy”.
For more information please see here or contact: partnering@bergenbio.com
We are looking forward to hearing from you!
